Cooling cap for chemotherapy
Phase 2
- Conditions
- Hair loss in chemotherapy.
- Registration Number
- IRCT20100706004329N12
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Less than 50 years old
Stage of breast cancer less than 4
Candidate for chemotherapy
Exclusion Criteria
Concurrent Leukemia
Liver disorders
Cold agglutinin disease
Cryoglobulinemia
Hypofibrinogenemia
Post-traumatic cold dystrophy
Cold-induced migraine
Inflammatory disease of skin of scalp
Hair loss disorder
Scalp disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of hair loss. Timepoint: Before intervention and 4 and 8 weeks after using cold cap. Method of measurement: National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE).
- Secondary Outcome Measures
Name Time Method Adverse effects. Timepoint: During and the day after using cold cap. Method of measurement: Asking patients.